Media OutReach Newswire

2024-08-09 10:00

Gene Solutions Announces Publication of Ground-breaking Study on AI-Driven Tumor-Specific Methylation Atlas

HO CHI MINH, VIETNAM - Media OutReach Newswire - 9 August 2024 - Gene Solutions, a pioneering genetic testing company in South-East Asia, is excited to announce the publication of a new peer-reviewed study that validates the analytical capabilities of its innovative, AI-driven Tumor-Specific Methylation Atlas (TSMA). The study, published in BMC Journal of Translational Medicine: "Tissue of origin detection (TOO) for cancer tumor using low-depth cfDNA samples through combination of tumor-specific methylation atlas and genome-wide methylation density in graph convolutional neural networks", details the robust analytical validation process which leverages advanced artificial intelligence to deliver precise and reliable tumor origin predictions in multi-cancer early detection.

Gene Solutions Announces Publication of Ground-breaking Study on AI-Driven Tumor-Specific Methylation Atlas

Firstly, the bioinformatics team from Gene Solutions used whole-genome bisulfite sequencing (WGBS) on five types of tumor tissues (breast, colorectal, gastric, liver and lung cancer) and paired white blood cells (WBC) to construct a tumor-specific methylation atlas (TSMA), where 2,945 CpG regions are discovered between tumor types and WBC. The team then implemented a Deep Learning model of Graph Convolutional Neural Network that combines deconvolution scores from the TSMA with other features to achieve an improved tumor of origin prediction accuracy in the validation dataset of 239 low-depth cfDNA samples.

By enhancing the accuracy of tumor identification through AI-driven method, the study opens up mutliple promises when applying in multi-cancer early detection tests:

Improved Data Accuracy: The combination demonstrated exceptional performance in accurately identifying the tumor of origin, notably up to 100%, 98% and 93% accuracies for breast, liver and colorectal cancer.

Reduced Sequencing Depth: By having a guiding atlas, the R&D team can optimize sequencing depth required for tumor identification, making it more efficient and cost-effective. This reduction in sequencing depth not only accelerates the time-to-result but also conserves costly next-generation sequencing resources.

Optimized Analysis Resources: The AI-driven approach optimizes the use of computational resources, reducing the overall cost and time required for tumor analysis. This optimization is a crucial step towards making advanced circulating tumor DNA analysis accessible and affordable for healthcare providers and patients alike.

Dr. Minh Duy Phan, a lead author of the study commented: "The analytical validation of the new tumor methylation atlas and deep learning algorithm marks a significant milestone in circulating tumor DNA analysis for early cancer signal detection. By harnessing the power of AI, we are enhancing the accuracy and efficiency of multi-cancer early detection technology for real-world utility."

Future Developments:

With further development by our data team, Gene Solutions is committed to expanding the capabilities of the TSMA. The ongoing research and development efforts aim to enable better quality analysis and application in real-life practice to reduce the cost of assays, ensuring that cutting-edge cancer screening tools are within reach for recommended individuals worldwide.

For more in-depth information about the study and the TSMA, please visit https://spotmas.com/blog/pioneering-a-tumor-specific-methylation-atlas-tsma-to-identify-tissue-of-origin-too-in-multi-cancer-early-detection/

References:

Nguyen, T.H., Doan, N.N.T., Tran, T.H. et al. Tissue of origin detection for cancer tumor using low-depth cfDNA samples through combination of tumor-specific methylation atlas and genome-wide methylation density in graph convolutional neural networks. J Transl Med 22, 618 (2024), doi: 10.1186/s12967-024-05416-z

Hashtag: #GeneSolutions

發佈者對本公告的內容承擔全部責任

About Gene Solutions:

Gene Solutions, a pioneering genetic testing company in South-East Asia, empowers healthcare decisions by providing accessible and critical insights. Their services include next-generation sequencing (NGS) tests that support reproductive health and clinical oncology. Gene Solutions specializes in non-invasive prenatal screening (NIPT), minimal residual disease (MRD) monitoring, multi-gene panel liquid biopsy, comprehensive genomic profiling (CGP), and multi-cancer early detection (MCED) tests. Leveraging clinically validated cell-free DNA analysis methods and artificial intelligence applications in bioinformatics, the company is committed to enable precision medicine. With a network of six international standard NGS Laboratories across Southeast Asia, Gene Solutions remains at the forefront of innovative genetic solutions.

source: Gene Solutions

想要獨家投資理財Tips?即Like etnet 全新Facebook專頁► 立即讚好

人氣文章
最近7天
1
高息定存 | 富邦推快閃定存優惠3個月3.9厘,華僑188日3.68厘
2
高息定存 | 6個月港元定存3.8厘新高,188日快閃優惠3.68厘
3
專訪|林本利系列專訪逢周五登場,股市篇:勿驚美股調整,港股那些可以放心買那些勿沾手(有片)
4
高息定存 | 工銀亞洲推3個月5厘息搶新客,招商永隆推快閃優惠
5
專訪|林本利系列專訪一連三個周五登場,樓市篇:中原指數長線重返180,買樓勿買新樓(有片)
6
高息定存 | 信銀國際上調1個月定存年息至高達3.88厘
7
神州經脈 | 特別國債或發3萬億,滬指逼近三千四,日外相訪華
8
回顧展望-新股復燃 | 政策市激發IPO 惟六成新股破發損行情
9
回顧展望-國際形勢 | 全球動盪戰火連天,特朗普時代重臨
10
高息定存 | 聖誕前夕銀行加存息吸資金,大眾3個月加至3.6厘
11
回顧展望-共渡時艱 | 表列機構對今明年本港經濟增長預測
12
回顧展望-樓盡六壬 | 甲廈租金明年料跌9%,華潤頻買民生商場
13
【FOCUS】「晶片戰」揮新大棒,技術制華恐適得其反
14
【FOCUS】「無厘頭」減息釀驚嚇,長債失控顯聯儲失信譽
15
【FOCUS】零售寒冬襲京滬港,逆市奇葩值借鏡
16
神州經脈 | 工業利潤降幅收窄,低空經濟發展司成立,滬指全周升
17
今日焦點股 | 據報螞蟻集團重組架構,劉政或出任首席財務官
18
港股 | 蕭猷華:恒指料退守至18600點,宜逢低吸納
19
內銀股 | 人行再提擇機減息降準,內銀獲中金唱好,應該點部署?
20
神州經脈 | 換手機可獲政府補貼,政策利率將降,滬指周挫逾5%
21
神州經脈 | PMI遜預期,滬指全年止跌回升,人幣年度貶幅擴
22
回顧展望-國際金融 | 金融市場現重要轉折,戰亂刺激避險
23
新股掛牌 | 布魯可首日掛牌升41%,每手賺7395元
24
回顧展望-息息相關 | 銀行股明年看好滙控,重組有利減低支出
25
高息定存 | 一周高息合集,銀行年尾搶資金,大眾3個月3.6厘
26
大國博弈 | 【FOCUS】騰訊商湯寧德重挫,CMC清單劍指軍民融合
27
高息定存 | 一周高息合集,恒生1個月定存4厘,工銀亞洲3個月最高5厘
28
回顧展望-人幣走貶 | 關稅殺到,先貶為敬,人幣明年勢見7.5
29
【FOCUS】華府停擺鬧劇又起,馬斯克功力再進化
30
港股 | 蕭猷華:恒指維持19700點至21000點上落
專業版
HV2
精裝版
SV2
串流版
IQ 登入
強化版
TQ
強化版
MQ

【etnet 30周年】多重慶祝活動一浪接一浪,好禮連環賞!

【etnet 賞你】賞 MOKO x Cheeky Cheeky「厚」有福氣利是封 及「熊 MEOW 」火柴盒造型年曆卡!

etnet榮獲HKEX Awards 2023 「最佳證券數據供應商」大獎

大國博弈

貨幣攻略

說說心理話

聖誕新年特輯

Watch Trends 2024

北上食買玩

Art Month 2024

秋天養生食療

山今養生智慧

輕鬆護老